vision-care
(4)
Wendy Hauteman
Wendy Hauteman is Chief Marketing Officer at VSP Vision, the Rancho Cordova-based not-for-profit vision care company that serves close to 90 million members through a network of 40,000 doctors. She has spent more than two decades in the optical industry, moving from senior marketing roles at Pearle Vision, ILORI and EyeMed to leading global strategic marketing at VSP before her promotion to CMO in August 2019. Under her leadership VSP shifted its message from 'we help people see' to 'empowering human potential through sight,' anchoring the brand's purpose-first playbook.
Matthias Hofmann
Matthias Hofmann is the co-founder and CEO of Eyebot, a Boston-based company building self-serve vision-test kiosks that deliver a 90-second refractive exam and pair users with a tele-optometrist. He holds a PhD in electrical engineering from Virginia Tech, did postdoctoral optics work at Harvard Medical School, and was an early engineer at MIT spinout EyeNetra before starting Eyebot in 2021 with Jack Moldave. In August 2025 Eyebot raised a $20M Series A led by General Catalyst.
John Serri
John A. Serri is a physicist-turned-entrepreneur and the co-founder, Chairman and CEO of EyeQue Corporation, a Newark, California company that turns an ordinary smartphone into a clinically registered eye-refraction device. With a PhD in Physics from MIT and 35 years spent building secure government networks and one of the world's largest satellite phone systems (Globalstar), Serri launched EyeQue in his 60s to make affordable vision testing available to anyone with a phone. Under his leadership EyeQue built its at-home Personal Vision Tracker on technology licensed from MIT, won CES 2017 Best of Innovation, amassed roughly 25 patents, and reached users in more than 150 countries.
Shivang Dave
Shivang R. Dave is the co-founder and CEO of PlenOptika, a Cambridge, Massachusetts medical-device company behind QuickSee, a handheld autorefractor that measures eyeglass prescriptions in about 10 seconds using wavefront aberrometry. A bioengineer with a PhD in bioengineering and nanotechnology, Dave co-invented the device during the Madrid-MIT M+Vision fellowship and has grown PlenOptika from a four-fellow research team into an international company whose technology has helped correct vision for over 7 million people across 60+ countries, especially in low-resource settings.